Caris Life Sciences CAI
NASDAQ CAI
$21.00 -2.04 (-8.85%)
At close: Nov 16, 2026 · 4:00 PM EST

Caris Life Sciences (CAI) Return on Equity [ROE] (2025 - 2026)

Updated

Caris Life Sciences (CAI) reported Return on Equity [ROE] of 15.60% for Q3 2026, up 55.76 percentage points from -40.16% a year earlier but down 2.14 percentage points from the prior quarter.

Analysis

Caris Life Sciences (CAI) Return on Equity [ROE] (2025 - 2026) Analysis & Trends

Dating back to Q3 2025, Caris Life Sciences' Return on Equity [ROE] record includes 5 quarters.

  • Five-year quarterly Return on Equity [ROE] spans a low of -40.16% in Q3 2025 and a high of 17.74% in Q2 2026.
  • Per Business Quant data, the three quarters before Q3 2026 came in at 17.74% (Q2 2026), 5.80% (Q1 2026) and -12.90% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 HCA Healthcare 109.68 Bn 104.04 Bn 17.03 Bn -
2 Natera 41.80 Bn 37.42 Bn 513.47 Mn -8.92%
3 Labcorp Holdings 30.24 Bn 28.33 Bn 1.11 Bn 11.52%
4 Quest Diagnostics 28.82 Bn 26.59 Bn 1.04 Bn 14.97%
5 Guardant Health 19.50 Bn 15.12 Bn 236.15 Mn -
6 BrightSpring Health Services 14.77 Bn 12.52 Bn 518.55 Mn 19.43%
7 Encompass Health 13.98 Bn 13.61 Bn 1.54 Bn 24.97%
8 Tempus AI 11.84 Bn 9.00 Bn 266.70 Mn -40.36%
9 Universal Health Services 11.63 Bn 11.07 Bn - 19.47%
10 Caris Life Sciences 5.98 Bn 2.79 Bn 182.29 Mn 15.54%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 15.54%
Jun 30, 2026 17.67%
Mar 31, 2026 5.87%
Dec 31, 2025 -12.81%
Sep 30, 2025 -40.06%
API Access

Caris Life Sciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CAI&period=max&api_key=YOUR_API_KEY